Oxygenta Pharma Financials

BSE: 524636

₹55.93

₹0.93 (1.69%)

As on 03-Sep-2026IST

Market cap

₹207 Cr

Revenue (TTM)

₹135 Cr

P/E Ratio

--

P/B Ratio

-4.6

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Operating Revenue	134.79	112.98	109.30	39.64	30.99	60.52
Total Income	134.98	113.27	110.61	39.68	31.01	60.53
Total Expenditure	142.83	128.29	119.11	49.34	38.10	59.05
EBITDA	-8.05	-15.31	-9.81	-9.70	-7.12	1.48
Depreciation	2.09	2.32	3.61	2.66	2.05	1.59
EBIT	-10.14	-17.63	-13.43	-12.36	-9.17	-0.12
Interest	6.61	4.83	2.23	1.59	1.49	0.92
Other Income	0.20	0.29	1.31	0.04	0.02	0.00
Exceptional Items	--	--	--	0.04	-0.73	0.55
Profit before Tax	-16.55	-22.18	-14.35	-13.87	-11.37	-0.49
Provision for Tax	-2.97	-4.61	-4.05	-10.39	0.20	0.12
Profit after Tax	-13.58	-17.57	-10.30	-3.48	-11.57	-0.61

Liabilities (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Shareholder's Funds	-42.69	-42.69	-25.64	-20.12	-46.20	-34.63
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	76.27	58.86	9.61	40.89	67.57	57.74
Current Liabilities	86.10	86.10	85.85	33.70	32.90	8.07
Total Liabilities	119.68	119.68	82.80	63.19	54.26	31.18

Assets (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Non-Current Assets	65.48	50.84	38.88	30.35	29.26	21.61
Current Assets	51.43	51.43	30.94	24.11	25.01	9.56
Total Assets	119.68	119.68	82.80	63.19	54.26	31.18
Total Debt*	--	109.57	62.23	57.23	67.99	52.13
Net Current Assets	-34.67	-34.67	-54.90	-9.59	-7.89	1.50
Contingent Liabilities	--	0.17	2.91	--	--	1.20

Cashflow (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Cash From Operating Activities	--	-27.75	2.83	-13.05	-1.63	-1.68
Cash Flow from Investing Activities	--	-14.39	-11.32	-4.09	-9.64	-4.94
Cash from Financing Activities	--	42.56	8.49	17.13	11.22	6.33
Net Cash Inflow / Outflow	--	0.42	--	-0.01	-0.05	-0.29

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Adjusted EPS (₹)	-3.67	-4.75	-2.78	-1.04	-8.15	-0.43
Cash EPS (₹)	-3.67	-4.12	-1.81	-0.24	-6.70	0.69
Adjusted Book Value (₹)	-12.11	-11.54	-6.93	-6.18	-32.53	-24.38
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-7.50	0.77	-3.90	-1.15	-1.18
Free Cash Flow per Share (₹)	--	-11.32	-2.03	-2.51	-2.33	-5.31

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
ROCE (%)	--	-33.53	-32.89	-41.69	-50.32	3.18
ROE (%)	--	--	--	--	--	--
ROA (%)	-13.41	-20.42	-16.57	-6.40	-27.09	-1.88
EBIT Margin (%)	-7.52	-15.61	-12.29	-31.17	-29.59	-0.19
Net Margin (%)	-10.06	-15.51	-9.31	-8.77	-37.32	-1.01
Cash Profit Margin (%)	--	-13.50	-6.12	-2.07	-30.72	1.62

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Revenue Growth (%)	19.23	3.37	175.71	27.93	-48.80	16.33
EBIT Growth (%)	36.85	-31.30	-8.67	-34.78	-7,849.79	-104.36
Net Profit Growth (%)	9.66	-70.63	-195.99	69.93	-1,795.44	-120.84
EPS Growth (%)	10.44	-70.62	-167.98	87.25	-1,795.28	-114.97
Book Value Growth (%)	--	-66.48	-23.96	55.23	-33.41	8.92

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Price / Earnings	-15.23	--	--	--	--	--
Price / Book Value	-4.62	-4.19	-11.48	-4.69	-1.13	-0.99
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-40.03	-19.06	-41.90	-15.97	-16.88	58.17
Close Price (₹)	48.49	48.38	79.56	28.99	36.60	24.05
High Price (₹)	121.60	133.50	108.64	52.27	40.54	37.00
Low Price (₹)	43.00	45.60	28.41	25.02	21.00	9.12
Market Cap (₹ Cr)	206.85	178.93	294.24	97.07	51.98	34.15

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debt to Equity	-1.76	-2.57	-2.43	-2.77	-1.47	-1.51
Short term debt to equity ratio	--	-0.74	-1.56	-0.37	-0.11	-0.03
Current Ratio	0.60	0.60	0.36	0.72	0.76	1.19
Quick Ratio	0.26	0.26	0.12	0.31	0.40	0.28
Interest Coverage	-1.50	-3.59	-5.43	-7.70	-6.65	0.47

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debtors to sales (%)	7.44	8.88	4.66	18.57	32.79	2.60
Asset Turnover	1.33	1.31	1.76	0.73	0.73	1.86
Receivable days	--	24.43	20.80	80.66	69.12	9.61
Inventory Days	--	80.66	57.15	117.03	111.83	58.49
Payable days	--	140.38	99.66	254.01	229.85	78.25
Cash Conversion Cycle	--	-35.29	-21.70	-56.32	-48.90	-10.16

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.